Early in the history of Duramax engines, GM changed the LB7 series of engines to LLY, but it can be difficult to tell them ...

The powerful V8 engines did so bearing the name LB7, and yes, they were eventually replaced by Duramax builds branded LLY. That changeover occurred just a few years after GM began producing ...

We recently published a list of 10 Best-Performing S&P 500 Stocks in the Last 3 Years. In this article, we are going to take a look at where Eli Lilly (NYSE:LLY) stands against other best ...

Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our P/B Growth Investor model based on the published strategy of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The prior-year-quarter earnings figure was impacted by $3 billion IPR&D charges recorded by the company, related to the acquisitions of DICE Therapeutics, Versanis Bio, and Emergence Therapeutics.

Year-over-year quarterly sales growth most recently was 20.4%. Analysts expect adjusted earnings to reach $13.189 per share for the current fiscal year. Eli Lilly and Company currently has a 0.6% ...

Eli Lilly LLY has outperformed the market over the past 20 years by 6.35% on an annualized basis producing an average annual return of 14.72%. Currently, Eli Lilly has a market capitalization of $ ...

Telehealth company Ro has rolled out a new tool to track the supply of weight loss drugs like Ozempic and Wegovy across the U.S., as patients struggle with shortages. Disney CEO Bob Iger will be ...

Eli Lilly's stock (NYSE:LLY) has been duly adjusted this AM following a surprise slash to its full year 2024 guidance. This marks a stark pivot from two consecutive quarters of raised revenue ...

But in the last few years, Eli Lilly was a great investment — mostly due to the success of Mounjaro and Zepbound. Nevertheless, the stock seems expensive — also when compared to Novo Nordisk ...